Larionov, A.; Fewings, E.; Redman, J.; Goldgraben, M.; Clark, G.; Boice, J.; Concannon, P.; Bernstein, J.; Conti, D.V.; the WECARE Study Collaborative Group;
et al. The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers 2023, 15, 415.
https://doi.org/10.3390/cancers15020415
AMA Style
Larionov A, Fewings E, Redman J, Goldgraben M, Clark G, Boice J, Concannon P, Bernstein J, Conti DV, the WECARE Study Collaborative Group,
et al. The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers. 2023; 15(2):415.
https://doi.org/10.3390/cancers15020415
Chicago/Turabian Style
Larionov, Alexey, Eleanor Fewings, James Redman, Mae Goldgraben, Graeme Clark, John Boice, Patrick Concannon, Jonine Bernstein, David V. Conti, the WECARE Study Collaborative Group,
and et al. 2023. "The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women" Cancers 15, no. 2: 415.
https://doi.org/10.3390/cancers15020415
APA Style
Larionov, A., Fewings, E., Redman, J., Goldgraben, M., Clark, G., Boice, J., Concannon, P., Bernstein, J., Conti, D. V., the WECARE Study Collaborative Group, & Tischkowitz, M.
(2023). The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers, 15(2), 415.
https://doi.org/10.3390/cancers15020415
